Wenyi Wei
- Oncology top 0.2%
- Cancer-related Molecular Pathways 58
- Peptidase Inhibition and Analysis 17
- Molecular Biology top 0.2%
- Ubiquitin and proteasome pathways 120
- Protein Degradation and Inhibitors 49
- PI3K/AKT/mTOR signaling in cancer 31
- Histone Deacetylase Inhibitors Research 20
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 24
- Aging top 0.5%
- Cell Biology top 0.5%
- Microtubule and mitosis dynamics 22
Wenyi Wei
230 papers receiving 17.4k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 5.9k
- Molecular Biology 13.3k
- Cancer Research 2.9k
- Aging 315
- Cell Biology 2.1k
Countries citing papers authored by Wenyi Wei
This map shows the geographic impact of Wenyi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Wei more than expected).
Fields of papers citing papers by Wenyi Wei
This network shows the impact of papers produced by Wenyi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Wei. The network helps show where Wenyi Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenyi Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 12 | |
| 6 | 2023 | 33 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 19 | |
| 9 | 2022 | 42 | |
| 10 | 2021 | 34 | |
| 11 | 2021 | 178 | |
| 12 | 2019 | 61 | |
| 13 | 2019 | 24 | |
| 14 | 2017 | 67 | |
| 15 | 2017 | 171 | |
| 16 | 2016 | 92 | |
| 17 | 2016 | 66 | |
| 18 | 2015 | 307 | |
| 19 | SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression | 2015 | 1 |
| 20 | COMPARATIVE RESEARCH ON THE STROKE RHYTHM OF MEN AND WOMEN KAYAKERS IN THE INTERNATIONAL COMPETITION | 2005 | 2 |
About Wenyi Wei
Wenyi Wei is a scholar working on Oncology, Molecular Biology, Cell Biology, Cancer Research and Geriatrics and Gerontology, having authored 240 papers that have together received 17.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (120 papers), Cancer-related Molecular Pathways (58 papers), Protein Degradation and Inhibitors (49 papers), PI3K/AKT/mTOR signaling in cancer (31 papers), Cancer, Hypoxia, and Metabolism (24 papers), Microtubule and mitosis dynamics (22 papers), Histone Deacetylase Inhibitors Research (20 papers) and Peptidase Inhibition and Analysis (17 papers). The work is most often cited by research in Oncology (5.9k citations), Molecular Biology (13.3k citations), Cancer Research (2.9k citations), Aging (315 citations) and Cell Biology (2.1k citations). Wenyi Wei has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Hiroyuki Inuzuka, John M. Sedivy, Zhiwei Wang, Pengda Liu, Lixin Wan, Jing Liu, Jinfang Zhang, Jianping Guo, Daming Gao and William G. Kaelin. Their work appears in journals such as Molecular Cell, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Nature Communications, Journal of the American Chemical Society and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.